Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The full report is titled “Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.” It is in the 2 August 2011 issue of Annals of Internal Medicine (volume 155, pages 179-191). The authors are A. Qaseem, T.J. Wilt, S.E. Weinberger, N.A. Hanania, G. Criner, T. van der Molen, D.D. Marciniuk, T. Denberg, H. Schünemann, W. Wedzicha, R. MacDonald, and P. Shekelle, for the American College of Physicians, the American College of Chest Physicians, the American Thoracic Society, and the European Respiratory Society.
Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline. Ann Intern Med. 2011;155:I-35. doi: 10.7326/0003-4819-155-3-201108020-00002
Download citation file:
Published: Ann Intern Med. 2011;155(3):I-35.
This article has been corrected. The original version (PDF) is appended to this article as a supplement.
The American College of Physicians (ACP) developed these recommendations in collaboration with the American College of Chest Physicians (ACCP), American Thoracic Society (ATS), and European Respiratory Society (ERS). Members of the ACP are internists, specialists in the care of adults.
Chronic obstructive pulmonary disease (COPD) occurs predominantly in cigarette smokers. People with COPD have narrowed airways, which makes it difficult to breathe, and may also have shortness of breath and wheezing. Spirometry can measure how much air a person can blow out in 1 second (called FEV1). The FEV1 can be used to diagnose COPD and assess its severity. Doctors treat COPD by helping patients who smoke to stop. They may also use inhaled beta-agonists or anticholinergics, corticosteroids, oxygen, or pulmonary rehabilitation (which includes education and exercise).
The authors reviewed recent studies on the benefits and harms of various tests and treatments for COPD.
A good indicator of risk for COPD is having smoked the equivalent of 1 pack per day for 55 years (55 pack-years). People who have never smoked or wheezed are unlikely to have COPD. The evidence does not support treating patients without COPD symptoms, even those with abnormal breathing test results, because such treatment does not improve outcomes. Moderate-quality evidence shows that inhaled beta-agonists, anticholinergics, and corticosteroids improve outcomes in symptomatic patients with an FEV1 less than 60%; moderate-quality evidence indicated benefit in such patients with an FEV1 between 60% and 80%. Moderate-quality evidence shows that pulmonary rehabilitation may help symptomatic patients with a low FEV1. Moderate-quality evidence shows that oxygen therapy helps patients with very low resting blood oxygen levels.
The guideline states that doctors should use spirometry to diagnose COPD in symptomatic patients, but not to look for COPD in patients without symptoms; consider treatment with long-acting beta-agonists, long-acting anticholinergics, or corticosteroids in symptomatic patients with an FEV1 of 60% to 80%; administer inhaled long-acting beta-agonists or long-acting anticholinergic bronchodilators in symptomatic patients with an FEV1 less than 60%; consider combination therapy with inhaled drugs if the FEV1 is less than 60% and symptoms continue after treatment with 1 drug; use pulmonary rehabilitation in symptomatic patients with an FEV1 less than 50%, and consider it for such patients with an FEV1 greater than 50%; and consider oxygen therapy for patients with COPD who have very low blood oxygen levels at rest.
These guidelines only considered studies published in 2007 to 2009.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Pulmonary/Critical Care, Chronic Obstructive Airway Disease.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only